Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02537425
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
BCZ | 3-(1-ACETYLAMINO-2-ETHYL-BUTYL)- 4-GUANIDINO-2-HYDROXY-CYCLOPENTANECARBOXYLIC ACID | A | 1L7G | 0.71 |  |
| BCZ | 3-(1-ACETYLAMINO-2-ETHYL-BUTYL)- 4-GUANIDINO-2-HYDROXY-CYCLOPENTANECARBOXYLIC ACID | A | 2HTU | 0.71 | |
| BCZ | 3-(1-ACETYLAMINO-2-ETHYL-BUTYL)- 4-GUANIDINO-2-HYDROXY-CYCLOPENTANECARBOXYLIC ACID | A | 2F10 | 0.71 | |
| BCZ | 3-(1-ACETYLAMINO-2-ETHYL-BUTYL)- 4-GUANIDINO-2-HYDROXY-CYCLOPENTANECARBOXYLIC ACID | A | 1L7H | 0.71 | |
| BCZ | 3-(1-ACETYLAMINO-2-ETHYL-BUTYL)- 4-GUANIDINO-2-HYDROXY-CYCLOPENTANECARBOXYLIC ACID | A | 1L7F | 0.71 | |
59A | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN- 2-YL]CARBONYL}-L-ISOLEUCINE | A | 2DC8 | 0.71 | |
U17 | METHYL N-[(2S,3R)-3-AMINO-2-HYDROXYHEPTANOYL]- L-SERYL-L-LEUCINATE | A | 2GGB | 0.7 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 3EMY | 0.72 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 2H6T | 0.72 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1LS5 | 0.72 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1SME | 0.72 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,C | 1W6I | 0.72 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1XDH | 0.72 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 2QZX | 0.72 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 1IZE | 0.72 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1M43 | 0.72 | |
OCQ | (3S)-3-[(2S)-2-AMINO-4-HYDROXY- 3-OXOBUTYL]PYRROLIDIN-2-ONE | A,I | 2Z3D | 0.7 | |
CHS | 4-AMINO-5-CYCLOHEXYL-3-HYDROXY- PENTANOIC ACID | I | 1E80 | 0.72 | |
| CHS | 4-AMINO-5-CYCLOHEXYL-3-HYDROXY- PENTANOIC ACID | I | 1EED | 0.72 | |
| CHS | 4-AMINO-5-CYCLOHEXYL-3-HYDROXY- PENTANOIC ACID | I | 2ER0 | 0.72 | |
ABW | 5-[1-(ACETYLAMINO)-3-METHYLBUTYL]- 2,5-ANHYDRO-3,4-DIDEOXY-4-(METHOXYCARBONYL)PENTONIC ACID | A | 1XOG | 0.74 | |
IVS | 3-HYDROXY-6-METHYL-4-(3-METHYL- 2-(3-METHYL-2-(3-METHYL-BUTYRYLAMINO)- BUTYRYLAMINO)-BUTYRYLAMINO)-HEPTANOIC ACID ETHYL ESTER | A,B | 1ME6 | 0.74 | |
ECQ | (3S)-3-[(2S)-2-AMINO-3-HYDROXYBUTYL]PYRROLIDIN- 2-ONE | A,I | 2Z3D | 0.7 | |